| Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial SE Kasner, B Swaminathan, P Lavados, M Sharma, K Muir, R Veltkamp, ... The Lancet Neurology 17 (12), 1053-1060, 2018 | 183 | 2018 |
| Lipoprotein (a) as a risk factor for ischemic stroke: a meta-analysis AH Nave, KS Lange, CO Leonards, B Siegerink, W Doehner, ... Atherosclerosis 242 (2), 496-503, 2015 | 176 | 2015 |
| Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data G Thomalla, F Boutitie, H Ma, M Koga, P Ringleb, LH Schwamm, O Wu, ... The Lancet 396 (10262), 1574-1584, 2020 | 138 | 2020 |
| Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension AH Nave, I Mižíková, G Niess, H Steenbock, F Reichenberger, ... Arteriosclerosis, thrombosis, and vascular biology 34 (7), 1446-1458, 2014 | 127 | 2014 |
| Lysyl oxidase activity is dysregulated during impaired alveolarization of mouse and human lungs A Kumarasamy, I Schmitt, AH Nave, I Reiss, I van der Horst, E Dony, ... American journal of respiratory and critical care medicine 180 (12), 1239-1252, 2009 | 97 | 2009 |
| Physical fitness training in patients with subacute stroke (PHYS-STROKE): multicentre, randomised controlled, endpoint blinded trial AH Nave, T Rackoll, U Grittner, H Bläsing, A Gorsler, DG Nabavi, ... Bmj 366, 2019 | 63 | 2019 |
| Hyperintense vessels, collateralization, and functional outcome in patients with stroke receiving endovascular treatment AH Nave, A Kufner, P Bücke, E Siebert, S Kliesch, U Grittner, H Bäzner, ... Stroke 49 (3), 675-681, 2018 | 39 | 2018 |
| Lipoprotein (a) levels and recurrent vascular events after first ischemic stroke KS Lange, AH Nave, TG Liman, U Grittner, M Endres, M Ebinger Stroke 48 (1), 36-42, 2017 | 39 | 2017 |
| Physical fitness training in Subacute Stroke (PHYS-STROKE)-study protocol for a randomised controlled trial A Flöel, C Werner, U Grittner, S Hesse, M Jöbges, J Knauss, M Seifert, ... Trials 15, 1-12, 2014 | 33 | 2014 |
| Cardiovascular events after ischemic stroke in young adults: a prospective follow-up study K Aarnio, B Siegerink, J Pirinen, J Sinisalo, M Lehto, E Haapaniemi, ... Neurology 86 (20), 1872-1879, 2016 | 32 | 2016 |
| Endothelial and leukocyte-derived microvesicles and cardiovascular risk after stroke: PROSCIS-B S Huo, N Kränkel, AH Nave, PS Sperber, JL Rohmann, SK Piper, ... Neurology 96 (6), e937-e946, 2021 | 23 | 2021 |
| Quantitative signal intensity in fluid-attenuated inversion recovery and treatment effect in the WAKE-UP trial B Cheng, F Boutitie, A Nickel, A Wouters, TH Cho, M Ebinger, M Endres, ... Stroke 51 (1), 209-215, 2020 | 22 | 2020 |
| Biomarkers and perfusion–training-induced changes after stroke (BAPTISe): protocol of an observational study accompanying a randomized controlled trial AH Nave, JM Kröber, P Brunecker, JB Fiebach, J List, U Grittner, ... BMC neurology 13, 1-7, 2013 | 17 | 2013 |
| Sleep‐disordered breathing in acute ischemic stroke: a mechanistic link to peripheral endothelial dysfunction N Scherbakov, A Sandek, N Ebner, M Valentova, AH Nave, ... Journal of the American Heart Association 6 (9), e006010, 2017 | 16 | 2017 |
| Evolution of blood-brain barrier permeability in subacute ischemic stroke and associations with serum biomarkers and functional outcome S Müller, A Kufner, A Dell'Orco, T Rackoll, R Mekle, SK Piper, JB Fiebach, ... Frontiers in neurology 12, 730923, 2021 | 15 | 2021 |
| Is lipoprotein (a) a risk factor for ischemic stroke and venous thromboembolism? AH Nave, A von Eckardstein Clinical research in cardiology supplements 14, 28-32, 2019 | 15 | 2019 |
| Assessment of thrombus length in acute ischemic stroke by post-contrast magnetic resonance angiography R Ganeshan, AH Nave, JF Scheitz, KA Schindlbeck, KG Haeusler, ... Journal of neurointerventional surgery 10 (8), 756-760, 2018 | 14 | 2018 |
| Altered cerebral glucose metabolism normalized in a patient with a pediatric autoimmune neuropsychiatric disorder after streptococcal infection (PANDAS)-like condition … AH Nave, P Harmel, R Buchert, L Harms BMC neurology 18, 1-5, 2018 | 12 | 2018 |
| Current Smoking Does Not Modify the Treatment Effect of Intravenous Thrombolysis in Acute Ischemic Stroke Patients—A Post-hoc Analysis of the WAKE-UP Trial L Schlemm, A Kufner, F Boutitie, AH Nave, C Gerloff, G Thomalla, ... Frontiers in Neurology 10, 1239, 2019 | 11 | 2019 |
| Elevated serum inflammatory markers in subacute stroke are associated with clinical outcome but not modified by aerobic fitness training: results of the randomized controlled … B Kirzinger, A Stroux, T Rackoll, M Endres, A Flöel, M Ebinger, AH Nave Frontiers in neurology 12, 713018, 2021 | 9 | 2021 |
